Patent directory · USPTO A61K / A61P
Patents matching “Takeda Pharmaceutical Company Limited”
1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11440883
Heterocyclic compound and use thereof
granted -
US 11433029
Formulation of an antibody and use thereof
granted -
US 11434304
Anti-CD38 antibodies
granted -
US 11426397
Piperidinyl- and piperazinyl-substituted heteroaromatic carboxamides as modulators of GPR6
granted -
US 11427605
Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl) phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl} pyrimidine-2,4-diamine
granted -
US 11414496
Anti-CD38 binding domains
granted -
US 11406710
Constrained conditionally activated binding proteins
granted -
US 11407748
Substituted pyrido[1,2-a]pyrimidines and pyrazino[1,2-a]pyrimidines for enhancing AMPA receptor function
granted -
US 11407984
Methods for purification of arysulfatase A
granted -
US 11401346
Nucleic acids encoding plasma kallikrein binding proteins
granted -
US 11390634
Fused heterocyclic compound
granted -
US 11390687
Bispecific antibodies against plasma kallikrein and Factor XII
granted -
US 11389533
Method of treating inflammatory bowel disease
granted -
US 11372002
Assays for determining plasma kallikrein system biomarkers
granted -
US 11370803
Heteroaryl plasma kallikrein inhibitors
granted -
US 11357832
Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfatase
granted -
US 11352356
Inhibitors of plasma kallikrein and uses thereof
granted -
US 11344610
Prevention and reduction of blood loss
granted -
US 11340237
Metabolite biomarkers for diseases associated with the contact activation system
granted -
US 11319286
Heterocyclic compound and application thereof
granted -
US 11299533
Purification of factor VIII subspecies
granted -
US 11299553
Anti-plasma kallikrein antibodies
granted -
US 11292766
Substituted piperidine compound and use thereof
granted -
US 11286307
Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
granted